Sonnet BioTherapeutics Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.17M, a 11.9% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$11.8M, a 36.9% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Income (Loss) for 2024 was -$11.8M, a 36.9% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$18.8M, a 36.7% increase from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$29.7M, a 18.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$11.8M -$3.17M +$427K +11.9% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-17
Q2 2024 -$12.3M -$3.53M +$387K +9.88% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$12.7M -$3.87M +$1.8M +31.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$14.5M -$1.28M +$4.33M +77.2% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$18.8M -$3.6M +$3.78M +51.2% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-17
Q2 2023 -$22.6M -$3.92M +$3.95M +50.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$26.5M -$5.66M +$2.55M +31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$29.1M -$5.61M +$603K +9.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$29.7M -$7.38M -$430K -6.19% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-14
Q2 2022 -$29.2M -$7.87M -$1.63M -26.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$27.6M -$8.21M -$2.17M -36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$25.4M -$6.21M -$351K -5.99% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 -$25.1M -$6.95M +$544K +7.27% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-15
Q2 2021 -$25.6M -$6.24M +$5.53M +47% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$31.2M -$6.04M -$3.53M -140% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$27.6M -$5.86M -$3.39M -138% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-08
Q3 2020 -$24.2M -$7.49M -$3.26M -77% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-17
Q2 2020 -$21M -$11.8M -$10.4M -738% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$10.6M -$2.51M -$816K -48.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$9.8M -$2.47M -$572K -30.2% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 -$9.23M -$4.23M -$3.56M -531% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 -$5.67M -$1.4M -$984K -234% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$4.68M -$1.69M +$686K +28.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 -$5.37M -$1.9M -$131K -7.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$5.24M -$671K +$727K +52% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$5.97M -$420K +$661K +61.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$6.63M -$2.38M -$1.39M -141% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$5.24M -$1.77M -$1.09M -160% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$4.15M -$1.4M -$881K -170% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.27M -$1.08M -$564K -109% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$2.7M -$989K -$83.3K -9.19% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.62M -$679K -$171K -33.7% Oct 1, 2016 Dec 31, 2016 10-Q 2018-05-15
Q3 2016 -$2.45M -$518K +$566K +52.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$3.01M -$518K +$1.07M +67.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-11-13
Q1 2016 -$4.08M -$906K +$996K +52.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$5.08M -$508K +$2.39M +82.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$7.47M -$1.08M -$552K -104% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$6.92M -$1.59M -$1.05M -198% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$5.86M -$1.9M -$318K -20.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$5.54M -$2.9M -$728K -33.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-31
Q3 2014 -$4.82M -$532K +$444K +45.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$5.26M -$532K +$155K +22.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-11-16
Q1 2014 -$5.42M -$1.58M -$809K -104% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 -$4.61M -$2.17M -$1.48M -215% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 -$3.13M -$976K -$215K -28.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$2.91M -$687K -$54.1K -8.54% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$2.86M -$775K -$267K -52.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$2.59M -$688K -$33.8K -5.16% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$2.56M -$761K -$475K -166% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 -$2.08M -$633K -$404K -176% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$1.68M -$509K -$723K -337% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$956K -$655K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-03
Q3 2011 -$286K -$132K -85.9% Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 -$229K -$42.5K -22.7% Apr 1, 2011 Jun 30, 2011 10-Q/A 2013-01-02
Q1 2011 $214K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-12-28
Q3 2010 -$154K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$187K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.